Explore the whitepaper on Engaging With Regulators on Novel Statistical Approaches to Clinical Development written by Scendea and Exploristics
CURRENT CHALLENGES IN DRUG DEVELOPMENT
The Pharmaceutical Industry is undergoing significant change as it faces extreme pressure to deliver new treatments to market at a time of increased spending in R&D. Multiple economic pressures are being exer ted on the industry, ranging from an impending patent cliff, a decrease in income due to greater competition from generics and biosimilars, to demands on drug pricing by governments. Each approved new drug costs around $3 billion to develop whilst healthcare providers seek to reduce the price paid for treatments making development costs unsustainable in the medium term. The current high at trition rate of treatments in development contributes to these high R&D costs, with 90% of treatments undergoing clinical trials failing to reach the market.
Pharma marketing is constantly changing and #AI is helping to reshape how brands connect with their audiences.
Discover Medico Digital top 5 #AI predictions and learn how harnessing the power of AI can boost your marketing strategy. Read more here.
Luscii provides the tools for patient and professional to keep an eye on the recovery while checking vital signs and symptoms to signal deteriorations and intervene timely in case of need.
Read more here.